Federal Supply Schedule 36F79721D0019
- The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
- The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 awarded a $972,177 Blanket Purchase Agreement (BPA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., to provide Decipher Prostate Cancer genomic testing services. This single-award IDV contract, utilizing the GSA Medical Laboratory Testing and Analysis Services Schedule, enables VISN 8 facilities to efficiently access Decipher's proprietary molecular diagnostic tests to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single-award Blanket Purchase Agreement to Decipher Biosciences, Inc., operating under Veracyte Labs SD Corp, against the Medical Laboratory Testing and Analysis Services schedule. The BPA call provides for prostate testing services in the amount of $390,000 to be performed over an 11-month period in San Diego, California. Specifically, the contractor will deliver Decipher Prostate...
- The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
- This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, has a ceiling value of $2,000,000 and an ultimate completion date of April 30, 2028. Under this contract, Veracyte will provide reference laboratory services, including specialized genomic testing and classifier services, to support...
- The federal contract IDV award is a single-award Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 (VISN 19) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The $1,424,021.22 BPA, awarded on October 1, 2025 with a performance period through September 30, 2030, enables VISN 19 to efficiently procure MDXHealth's specialized cancer diagnostic...
- The federal contract IDV award is held by Cepheid, a for-profit manufacturer of molecular diagnostic solutions including tests for infectious diseases and genetic conditions. The contract, valued at a ceiling of $14,608,507.24, is with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 for the procurement of Cepheid reagents and test kits. This single-award indefinite delivery contract enables the VA to continuously obtain Cepheid's molecular diagnostic products to...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 and Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $3,426,923.40 and a period of performance extending to June 30, 2029. Under this IDC, Cepheid will provide the VA with a reagent lease for its molecular diagnostic testing equipment and associated...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- 36F79721D0019Federal Supply Schedule
- Blanket Purchase Agreements
- 22Federal Contract Awards
The key products and services being delivered under this federal contract IDV award are specialized genomic testing services, primarily focused on prostate cancer diagnostics and treatment planning. The prime contractor, Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., provides its proprietary Decipher Prostate Cancer Test and other advanced molecular diagnostic capabilities to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Networks (VISNs) across the country. The contract was awarded under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), allowing the VA to efficiently access Veracyte's specialized testing services through a combination of firm fixed-price delivery orders, Blanket Purchase Agreements (BPAs), and task orders. These IDV contracts, valued from hundreds of thousands to over $1.9 million, enable the VA to support precision cancer care for veterans by analyzing tumor gene expression patterns to predict cancer aggressiveness and metastatic risk. The contracts do not utilize any set-aside designations, as Veracyte's services are highly specialized and not typically available from small businesses. The majority of the services are performed at Veracyte's facilities in California, Michigan, Tennessee, and Texas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00010 | Add Subcontract Plan | $0 | 4/22/25 | |
| P00009 | Rerepresentation | $0 | 2/18/25 | |
| P00008 | Other Administrative Action | $0 | 1/26/24 | |
| P00007 | Novation Agreement | $0 | 5/4/23 | |
| P00006 | Other Administrative Action | $0 | 9/13/22 |
Name | Description | Awardee | Potential Value | AwardDate | LastDateToOrder | Updated At |
|---|---|---|---|---|---|---|
36F79721D0019-36C24823A0010 | Veracyte Labs SD Corporation | $972.2k | 2/8/23 | 1/31/28 | 1/29/25 | |
36F79721D0019-36C24123A0032 | Veracyte Labs SD Corporation | $2.0m | 2/7/23 | 1/31/28 | 2/7/23 | |
36F79721D0019-36C25722A0004 | Veracyte Labs SD Corporation | $991.8k | 12/7/21 | 11/14/26 | 6/9/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C25722A0004-36C25722N0120 | Veracyte Labs SD Corporation | $3.2k | 12/7/21 | 11/14/22 | 3/23/23 | |
BPA Call 36C24823A0010-36C24825N0342 | Veracyte Labs SD Corporation | $194.4k | 2/1/25 | 1/31/26 | 1/30/25 | |
Delivery Order 36F79721D0019-36C25023N0579 | Veracyte Labs SD Corporation | $84.3k | 7/20/23 | 7/19/26 | 6/23/25 | |
BPA Call 36C24123A0032-36C24125N0488 | Veracyte Labs SD Corporation | $300.0k | 2/1/25 | 1/31/26 | 1/30/25 | |
Delivery Order 36F79721D0019-36C26121N0873 | Veracyte Labs SD Corporation | $136.1k | 9/8/21 | 9/7/22 | 2/19/23 |
Name | Description | Size | Type | Posted |
|---|---|---|---|---|
FSS-621-II - Veracyte Labs SD Corporation - 36F79721D0019.pdf | 219KB | Not listed |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--Decipher Corp. Award Effective 11/15/2020 - 11/14/2025 | 621II | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Award Notice 1/1 | 11/2/20, 10:34 AM |